Wednesday, May 29, 2013

Quote of the Month: Enough is Enough!

Imam Mohamed Magid, left, and Rabbi Robert Nosanchuk, pictured last year when they were named "Washingtonians of the Year" by The Washingtonian magazine, are continuing their effort to promote understanding between Muslims and Jews. Photo Credit: Matthew Worden, courtesy of The Washingtonian magazine.

“Whether in Europe today or in the Muslim world, my call to humanity: End racism, for God’s sake, end anti-Semitism, for God’s sake, end Islamophobia for God’s sake, end sexism for God’s sake… Enough is enough.” 

~ Imam Mohamed Magid, President of the Islamic Society of North America (ISNA), at historic Muslim leaders prayer for peace at Auschwitz, Poland, on Wednesday May 22, 2013.

submit to reddit

Goethe Institut and DVWORX Studios Support Screen Naija One Village, One Cinema

The German Goethe-Institut in Nigeria and DVWORX Studios in Lagos have joined the partners of Screen Outdoor Open Air Cinema (SOOAC) for the launching of Screen Naija One Village, One Cinema at the Freedom Park Lagos on Saturday June 22, 2013.
The inaugural launching sponsored by the Bank of Industry of Nigeria is open to the public from 4 pm - 9 pm and it is free.

Expected at the event are over 500 people; including the new brand ambassador of the Bank of Industry Afro hip hop super star Dapo Daniel Oyebanjo, popularly known as D'banj, Nollywood stars, movie buffs, entertainment celebrities and major stakeholders in the Nigerian film industry.

Screen Outdoor Open Air Cinema duly registered to operate outdoor cinema business in Nigeria will launch the Screen Naija One Village, One Cinema Project in every conducive and receptive safe community of all the local government areas (LGAs) in Nigeria starting from Lagos State to boost the Nigerian film industry.

submit to reddit

Tuesday, May 28, 2013

UN Calls for Investigation Into the Murder of Congolese Radio Presenter

28 May 2013 00:24 Africa/Lagos


NEW YORK, 27 May 2013 / PRNewswire Africa / - The head of the United Nations agency tasked with defending press freedom today called for an investigation into the murder of a journalist in the Democratic Republic of the Congo (DRC), Guylain Chanjabo.

"I condemn the murder of Guylain Chanjabo and urge authorities in the Democratic Republic of Congo to do their utmost to shed light on his tragic death, and bring those responsible to justice," said the Director-General of the UN Educational, Scientific and Cultural Organization (UNESCO), Irina Bokova.

Mr. Chanjabo presented a Swahili language programme on Radio Canal Revelation, and was reported missing on 5 May. His body was found bearing evidence of neck injuries on 17 May in the Ngezi River, five kilometres from the city of Bunia in the northeastern region of the DRC.

"Freedom of expression is an irrevocable right in democratic societies, necessary for the rule of law and allowing citizens to take part in informed debate," Ms. Bokova said.

According to Reporters Without Borders, Mr. Chanjabo had been violently attacked six months ago, and, just before his disappearance, had been beaten in a bar by an unidentified person who criticized the content his programmes.

SOURCE : UN News Centre

Releases displayed in Africa/Lagos time
28 May 2013
10:00 Qualified Public Schools Teachers Face a Hot Job Market - in Abu Dhabi
09:00 ManpowerGroup Annual Talent Shortage Survey Reveals U.S. Employers Making Strides to Build Sustainable Workforces, Report Less Difficulty Filling Open Positions
09:00 Middle East's most specialized exhibitions of China-made products opened today to boost trade between China and the MENA region
09:00 CNH Global Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations for a Faster Close
00:33 Freedom of Expression, Association, and Assembly Confiscated by the “Arab Spring” Governments
00:30 African Union Kwame Nkrumah Scientific Awards 2013
00:21 African Union Commission's Strategic Plan 2014-2017 adopted by Assembly
00:18 FIDH - Iranian lawyer Karim Lahidji elected President of FIDH
00:15 AfDB and its Partners to Focus on Africa's Future at Annual Meetings in Morocco
00:11 AfDB's New Disclosure and Access to Information Policy will Promote AfDB Ten-Year Strategy Objectives
00:08 Readout of the Deputy Secretary-General's meeting with H.E. Ms. Kristalina Georgieva, European Commissioner for International Cooperation, Humanitarian Aid and Crisis Response
00:02 Readout of the Deputy Secretary-General's meeting with H.E. Mr. José Manuel Barroso, President of the European Commission

submit to reddit

Friday, May 17, 2013

"Star Trek into Darkness" is the #1 Most Anticipated Movie This Weekend

May 15 - Director J.J. Abrams leads the cast of ''Star Trek Into Darkness'' at the sci-fi film's Hollywood premiere. John Russell reports.

16 May 2013 16:09 Africa/Lagos

"Star Trek into Darkness" Beams Up Fandango's Fanticipation Buzz Indicator as the #1 Most Anticipated Movie This Weekend

LOS ANGELES, May 16, 2013 /PRNewswire/ -- Fandango, the nation's leading moviegoer destination, reported today that J.J. Abrams' highly anticipated "Star Trek Into Darkness" garnered a 96 out of 100 score on the company's Fanticipation movie buzz indicator that measures fan sentiment around the weekend box office line-up. The sci-fi thriller outshone "Iron Man 3" and "The Great Gatsby," which are still top-of-mind with moviegoers, scoring 85 and 83, respectively. Fanticipation scores are calculated based a proprietary analysis of Fandango's advance ticket sales, website and mobile traffic, and social media engagement.



Flying at maximum warp speed, "Star Trek" also represents 80% of today's ticket sales on Fandango, selling out hundreds of show times across the country, from New York to San Francisco, and Atlanta to Austin.

More than 1,000 "Star Trek" ticket-buyers participated in a survey on Fandango and excitement for the film and the franchise is running high:

89% said they had seen the previous J.J. Abrams "Star Trek" on the big screen;
76% have avoided reading any online spoilers, saying they want to be completely surprised;
71% said that co-star Benedict Cumberbatch, star of TV's "Sherlock," increased their interest in seeing the movie;
62% will attend the movie with a group of fellow "Star Trek" fans;
56% said the secrecy surrounding the film made them even more excited to see the film;
55% already plan to see the movie more than once;
15% will be dressed in "Star Trek" attire at the theater.

On this week's episode of "Weekend Ticket," Fandango's weekly digital video series, Fandango Chief Correspondent and Host Dave Karger interviews the film's stars Chris Pine and Zachary Quinto and challenges them to a "Star Trek" trivia face-off. Fans can see which of the two leading men is the master at "Trek" trivia at

About Fandango
Fandango, the nation's leading moviegoer destination and an NBCUniversal company, sells tickets to more than 21,000 screens nationwide. Fandango entertains and informs consumers with reviews, commentary, celebrity interviews and trailers, and offers the ability to quickly select a film, plan where and when to see it, and conveniently buy tickets in advance. For many theaters, fans can print their tickets at home or receive them as a paperless Mobile Ticket on their smartphones. Fandango's top-ranking movie ticketing apps, with 33 million downloads, are available on the iPhone and iPad, Android, and many other platforms. Fandango is enjoyed by more than 41 million online and mobile visitors per month. Film fans find Fandango on Facebook at and on Twitter @Fandango.


Dana Henry Benson

Elizabeth Schmidt

310-954-0278 x300


SOURCE Fandango

Web Site:

submit to reddit

Monday, May 13, 2013

Top 10 U.S Box Office for Second Weekend of May 2013

  1. Iron Man 3 - Disney - $72.5M
  2. Great Gatsby, The - Warner Bros. - $51.1M
  3. Pain And Gain - Paramount - $5.0M
  4. Tyler Perry Presents Peeples - Lionsgate - $4.8M
  5. 42 - Warner Bros. - $4.7M
  6. Oblivion - Universal - $3.9M
  7. Croods, The - 20th Century Fox - $3.6M
  8. Big Wedding, The - Lionsgate - $2.5M
  9. Mud - Roadside Attractions - $2.3M
  10. Oz The Great and Powerful - Disney - $0.8M 

See the top-12 domestic weekend box office estimates listed in descending order, per data collected as of Sunday, May 12, 2013.

submit to reddit

Friday, May 10, 2013

Sisterhood of the Traveling Pants

Sisterhood of the Traveling Pants

Coming-of-age adventure based on Ann Brashares' best-selling novel about a special sixteenth summer in the lives of four lifelong friends who are separated for the first time. On a shopping trip, the girls find a pair of thrift-shop jeans that fits each of them perfectly and they decide to use these 'magic' pants as a way of keeping in touch over the months ahead, each girl wearing the jeans for a week to see what luck they bring her before sending them on to the next. Though miles apart, the four friends still experience life, love and loss together in a summer they'll never forget.

submit to reddit

Monday, May 06, 2013

Sanofi US and Actress Elizabeth Perkins Premiere Documentary “Strength in Numbers”

Sanofi US and Actress Elizabeth Perkins Premiere Documentary —Diabetes Co-Stars Presents “Strength in Numbers”
–Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views–

Elizabeth Perkins wth her co-star and husband, Julio Macat.

Bridgewater, New Jersey – May 6, 2013 – /PRNewswire/ &ndash Sanofi US and Golden Globe and Emmy nominated actress Elizabeth Perkins proudly premiered the Diabetes Co-Stars documentary, “Strength in Numbers,” at the American Diabetes Association Expo in Los Angeles, CA this past weekend. The film, produced by Elizabeth and her ‘co-star’ and husband Julio Macat, features her diabetes story as well as two other inspirational stories from the 2012 Diabetes Co-Stars casting call contest – best friends Amanda Bauer and Anne Casey from New York, and father-daughter duo Eugenio and Naiomi Rivera from Texas.

The pairs were selected because of their empowering stories of dedication and support, with Amanda and Anne giving back to their community by spearheading support groups for youth living with diabetes, and Eugenio and Naiomi guiding one another through their daily diabetes management. The documentary highlights their stories, in addition to Elizabeth and Julio’s, and can be viewed online at

“Hearing these stories, I truly identified with the level of support and caring these people showed one another and was so excited to feature them in this documentary,” said Elizabeth Perkins, star of the new ABC sitcom ‘How to Live with Your Parents (For the Rest of Your Life).’ “The Diabetes Co-Stars program is close to my heart because it celebrates those who support the 26 million Americans living with diabetes every day and this film shines a light on these inspiring people.”

Perkins, who is living with type 1 diabetes, produced the documentary as part of her partnership with Sanofi US on the Diabetes Co-Stars campaign, which has brought awareness to millions of Americans about the power of a support team for people living with diabetes since the program’s launch in 2010. She currently uses Lantus® SoloSTAR® (insulin glargine [rDNA origin] injection) as part of her overall diabetes treatment plan, along with exercise, healthy diet and the support from her family and friends.

As part of the program, Sanofi US is supporting the Diabetes Hands Foundation and its efforts to encourage an open dialogue around the realities of living with diabetes.

“We are so thankful to Sanofi US for their continued support in our mission to connect, engage, and empower people touched by diabetes,” said Manny Hernandez Co-Founder and President of Diabetes Hands Foundation. “You can make an even bigger impact by watching the documentary online.”

When “Strength in Numbers” reaches 10,000 online views, Sanofi US will double its initial donation for a total of $20,000.

To learn more about how you can support your loved ones with diabetes, please visit, and follow the Sanofi US Diabetes Facebook page and Twitter feed for additional updates.

Indications and Usage for Lantus (insulin glargine [rDNA origin] injection)

Prescription Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and children (6 years and older) with type 1 diabetes for the control of high blood sugar. It should be taken once a day at the same time each day to lower blood glucose.

Do not use Lantus to treat diabetic ketoacidosis.

Important Safety Information for Lantus (insulin glargine [rDNA origin] injection)

Do not take Lantus if you are allergic to insulin or any of the inactive ingredients in Lantus.

You must test your blood sugar levels while using insulin, such as Lantus. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus must only be used if the solution is clear and colorless with no particles visible. Do not share needles, insulin pens or syringes with others.

The most common side effect of insulin, including Lantus, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia may be serious and life threatening. It may cause harm to your heart or brain. Other possible side effects may include injection site reactions, including changes in fat tissue at the injection site, and allergic reactions, including itching and rash. In rare cases, some allergic reactions may be life threatening.

Tell your doctor about other medicines and supplements you are taking because they can change the way insulin works. Before starting Lantus, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed.

Lantus SoloSTAR is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

For Full Prescribing Information for Lantus® please visit or call 1-800-633-1610.

About Diabetes

Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin, the hormone needed to transport glucose (sugar) from the blood into the cells of the body for energy. It is estimated that 371 million people worldwide and nearly 26 million Americans have diabetes, including an estimated 7 million Americans who remain undiagnosed. At the same time, approximately 40 percent of those diagnosed are not achieving the blood sugar control target of A1C <7 a1c="" american="" association="" average="" b="" blood="" by="" diabetes="" glucose="" levels="" measures="" over="" past="" percent="" period.="" recommended="" test="" the="" three-month="" two-to="">About Sanofi Diabetes

Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices including innovative blood glucose monitoring systems. Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes. Investigational compounds in the pipeline include an injectable GLP-1 agonist being studied as a single agent, in combination with basal insulin, and/or in combination with oral antidiabetic agents.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US. For more information on Sanofi US, please visit or call 1-800-981-2491.

Media Contacts:

Rachel Ferrand
Specialist, U.S. Communications
Tel.: (908) 981-6673


submit to reddit

What Has Jomo Gbomo Got To Do With Brad Pitt in the Niger Delta?

What do you think will link the famous spokesman of the Movement for the Emancipation of the Niger Delta (MEND) Jomo Gbomo and famous Hollywood actor Brad Pitt?
"Big Men" whose greed is the subject of this film on oil and war in the Niger Delta and also in Ghana.

"I was traveling with Sebastian Junger in the Niger Delta, he was writing an article for Vanity Fair, and he had had some correspondence with this guy called Jomo Bomo, who was basically the publicist for the militants. He had written Jomo Bomo saying, hey, can I get access and Jomo Bomo had written back saying, I don’t know who you are, you are out of luck. And then apparently Jomo looked him up on the internet and read about The Perfect Storm. Once he figured out who Sebastian Junger is he said, 'Oh, no problem, I’ll give you access, just give me a signed copy of your book.' So I thought, I need to bring on an executive producer that means something, and I went home and I asked Brad Pitt to executive produce the movie, and he read the pitch and he got really excited."

~ Rachel Boynton first went to Africa to research her documentary Big Men, which premiered this week at the Tribeca.

Read more: